Quadruple Cancers of Non-producing Multiple Myeloma, Cholangiocellular Carcinoma, and Two Different Thyroid Cancers
INTERNAL MEDICINE (2016)
期刊
INTERNAL MEDICINE
卷 55, 期 9, 页码 1183-1186出版社
JAPAN SOC INTERNAL MEDICINE
关键词
作者
我是这篇论文的作者
推荐
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma
Frank Cichocki, Ryan Bjordahl, Jodie P. Goodridge, Sajid Mahmood, Svetlana Gaidarova, Ramzey Abujarour, Zachary B. Davis, Aimee Merino, Katie Tuininga, Hongbo Wang, Akhilesh Kumar, Brian Groff, Alec Witty, Greg Bonello, Janel Huffman, Thomas Dailey, Tom T. Lee, Karl-Johan Malmberg, Bruce Walcheck, Uta Hoepken, Armin Rehm, Bahram Valamehr, Jeffrey S. Miller
NATURE COMMUNICATIONS (2022)
Multiple myeloma
Niels W. C. J. van de Donk, Charlotte Pawlyn, Kwee L. Yong
LANCET (2021)
Functional dissection of inherited non-coding variation influencing multiple myeloma risk
Ram Ajore, Abhishek Niroula, Maroulio Pertesi, Caterina Cafaro, Malte Thodberg, Molly Went, Erik L. Bao, Laura Duran-Lozano, Aitzkoa Lopez de Lapuente Portilla, Thorunn Olafsdottir, Nerea Ugidos-Damboriena, Olafur Magnusson, Mehmet Samur, Caleb A. Lareau, Gisli H. Halldorsson, Gudmar Thorleifsson, Gudmundur L. Norddahl, Kristbjorg Gunnarsdottir, Asta Forsti, Hartmut Goldschmidt, Kari Hemminki, Frits van Rhee, Scott Kimber, Adam S. Sperling, Martin Kaiser, Kenneth Anderson, Ingileif Jonsdottir, Nikhil Munshi, Thorunn Rafnar, Anders Waage, Niels Weinhold, Unnur Thorsteinsdottir, Vijay G. Sankaran, Kari Stefansson, Richard Houlston, Bjorn Nilsson
NATURE COMMUNICATIONS (2022)
Functional dissection of inherited non-coding variation influencing multiple myeloma risk
Ram Ajore, Abhishek Niroula, Maroulio Pertesi, Caterina Cafaro, Malte Thodberg, Molly Went, Erik L. Bao, Laura Duran-Lozano, Aitzkoa Lopez de Lapuente Portilla, Thorunn Olafsdottir, Nerea Ugidos-Damboriena, Olafur Magnusson, Mehmet Samur, Caleb A. Lareau, Gisli H. Halldorsson, Gudmar Thorleifsson, Gudmundur L. Norddahl, Kristbjorg Gunnarsdottir, Asta Foersti, Hartmut Goldschmidt, Kari Hemminki, Frits van Rhee, Scott Kimber, Adam S. Sperling, Martin Kaiser, Kenneth Anderson, Ingileif Jonsdottir, Nikhil Munshi, Thorunn Rafnar, Anders Waage, Niels Weinhold, Unnur Thorsteinsdottir, Vijay G. Sankaran, Kari Stefansson, Richard Houlston, Bjorn Nilsson
NATURE COMMUNICATIONS (2022)
The Multiple Myeloma Landscape: Epigenetics and Non-Coding RNAs
Isabel F. Coira, Rafael Rincon, Muriel Cuendet
CANCERS (2022)
Long non-coding RNAs in multiple myeloma (Review)
Chenbo Yang, Yinghao Liang, Jiao Shu, Shuaiyuan Wang, Yichen Hong, Kuisheng Chen, Miaomiao Sun
INTERNATIONAL JOURNAL OF ONCOLOGY (2023)
Percutaneous Screw Stabilization of Non-Periacetabular Pelvic Lesions Caused by Metastatic Cancer and Multiple Myeloma
Rui Yang, Swapnil Singh, Alessandra Falk, Jichuan Wang, Beverly Thornhill, Jana Fox, Milan Sen, Bang Hoang, David S. Geller
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2022)
Mezigdomide and Multiple Myeloma
Jake Shortt
NEW ENGLAND JOURNAL OF MEDICINE (2023)
Synergistically Anti-Multiple Myeloma Effects: Flavonoid, Non-Flavonoid Polyphenols, and Bortezomib
Kaixi Ding, Wei Jiang, Huanan Jia, Ming Lei
BIOMOLECULES (2022)
Genomic Instability in Multiple Myeloma: A Non-Coding RNA Perspective
Elisa Taiana, Maria Eugenia Gallo Cantafio, Vanessa Katia Favasuli, Cecilia Bandini, Giuseppe Viglietto, Roberto Piva, Antonino Neri, Nicola Amodio
CANCERS (2021)
Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma
Yasmeen Niazi, Nagarajan Paramasivam, Joanna Blocka, Abhishek Kumar, Stefanie Huhn, Matthias Schlesner, Niels Weinhold, Rolf Sijmons, Mirjam De Jong, Brian Durie, Hartmut Goldschmidt, Kari Hemminki, Asta Foersti
CELLS (2023)
Nanoparticles Dual Targeting Both Myeloma Cells and Cancer-Associated Fibroblasts Simultaneously to Improve Multiple Myeloma Treatment
Honglan Wang, Huiwen Liu, Chunyan Sun, Chunying Liu, Ting Jiang, Yanxue Yin, Aoshuang Xu, Zhiqing Pang, Bo Zhang, Yu Hu
PHARMACEUTICS (2021)
Multiple myeloma: what a non-haematologist should know
Taran K. Nandra, Amarpreet Devi, John R. Jones
CLINICAL MEDICINE (2022)
A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma
Aristea-Maria Papanota, Paraskevi Karousi, Christos K. Kontos, Pinelopi I. Artemaki, Christine-Ivy Liacos, Maria-Alexandra Papadimitriou, Tina Bagratuni, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Efstathios Kastritis, Margaritis Avgeris, Meletios-Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
BMI1 regulates multiple myeloma-associated macrophage's pro-myeloma functions
Danfeng Zhang, Jingcao Huang, Fangfang Wang, Hong Ding, Yushan Cui, Yan Yang, Juan Xu, Hongmei Luo, Yuhan Gao, Ling Pan, Yu Wu, Yuping Gong, Liping Xie, Zhigang Liu, Ying Qu, Li Zhang, Weiping Liu, Wenyan Zhang, Sha Zhao, Qing Yi, Ting Niu, Yuhuan Zheng
CELL DEATH & DISEASE (2021)
Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105)
Dai Maruyama, Shinsuke Iida, Gakuto Ogawa, Noriko Fukuhara, Sachiko Seo, Kana Miyazaki, Makoto Yoshimitsu, Junya Kuroda, Norifumi Tsukamoto, Hideki Tsujimura, Akira Hangaishi, Takahiro Yamauchi, Takahiko Utsumi, Ishikazu Mizuno, Yasushi Takamatsu, Yasuyuki Nagata, Koichiro Minauchi, Eiichi Ohtsuka, Ichiro Hanamura, Shinichiro Yoshida, Satoshi Yamasaki, Youko Suehiro, Yutaro Kamiyama, Kunihiro Tsukasaki, Hirokazu Nagai
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Mantle cell lymphoma with EBV-positive Hodgkin and Reed-Sternberg-like cells in a patient after autologous PBSCT: Phenotypically distinct but genetically related tumors
Risa Kanai, Aya Miyagawa-Hayashino, Yukiko Shishido-Hara, Naoya Nakamura, Ikoi Omatsu, Yukiko Morinaga, Yuji Shimura, Junya Kuroda, Tetsuya Imura, Kyoko Itoh, Eiichi Konishi
PATHOLOGY INTERNATIONAL (2021)
Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis
Teruhito Takakuwa, Ryosuke Yamamura, Kensuke Ohta, Hitomi Kaneko, Kazunori Imada, Aya Nakaya, Shin-ichi Fuchida, Hirohiko Shibayama, Mitsuhiro Matsuda, Yutaka Shimazu, Yoko Adachi, Satoru Kosugi, Hitoji Uchiyama, Hirokazu Tanaka, Hitoshi Hanamoto, Yuji Shimura, Junya Kanda, Yoshiyuki Onda, Nobuhiko Uoshima, Hideo Yagi, Satoshi Yoshihara, Masayuki Hino, Chihiro Shimazaki, Akifumi Takaori-Kondo, Junya Kuroda, Itaru Matsumura, Yuzuru Kanakura, Shosaku Nomura
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma
Teruhito Takakuwa, Kensuke Ohta, Eiji Nakatani, Tomoki Ito, Hitomi Kaneko, Shin-Ichi Fuchida, Yuji Shimura, Hideo Yagi, Hirohiko Shibayama, Junya Kanda, Hitoji Uchiyama, Satoru Kosugi, Hirokazu Tanaka, Eri Kawata, Nobuhiko Uoshima, Jun Ishikawa, Masaru Shibano, Takahiro Karasuno, Maki Shindo, Yoshifumi Shimizu, Kazunori Imada, Yuzuru Kanakura, Junya Kuroda, Masayuki Hino, Shosaku Nomura, Akifumi Takaori-Kondo, Chihiro Shimazaki, Itaru Matsumura
HEMATOLOGICAL ONCOLOGY (2021)
Combination of Bone Marrow Biopsy and Flow Cytometric Analysis: The Prognostically Relevant Central Approach for Detecting Bone Marrow Invasion in Diffuse Large B-Cell Lymphoma
Haruya Okamoto, Nobuhiko Uoshima, Ayako Muramatsu, Reiko Isa, Takahiro Fujino, Yayoi Matsumura-Kimoto, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Tsutomu Kobayashi, Eri Kawata, Hitoji Uchiyama, Junya Kuroda
DIAGNOSTICS (2021)
Expression of activated B-cell gene signature is predictive of the outcome of follicular lymphoma
Taku Tsukamoto, Yuichi Tokuda, Masakazu Nakano, Kei Tashiro, Junya Kuroda
BLOOD ADVANCES (2022)
The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma
Reiko Isa, Mano Horinaka, Taku Tsukamoto, Kentaro Mizuhara, Yuto Fujibayashi, Yoko Taminishi-Katsuragawa, Haruya Okamoto, Shusuke Yasuda, Yuka Kawaji-Kanayama, Yayoi Matsumura-Kimoto, Shinsuke Mizutani, Yuji Shimura, Masafumi Taniwaki, Toshiyuki Sakai, Junya Kuroda
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia
Seiichiro Katagiri, SungGi Chi, Yosuke Minami, Kentaro Fukushima, Hirohiko Shibayama, Naoko Hosono, Takahiro Yamauchi, Takanobu Morishita, Takeshi Kondo, Masamitsu Yanada, Kazuhito Yamamoto, Junya Kuroda, Kensuke Usuki, Daigo Akahane, Akihiko Gotoh
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105)
Dai Maruyama, Shinsuke Iida, Ryunosuke Machida, Shigeru Kusumoto, Noriko Fukuhara, Nobuhiko Yamauchi, Kana Miyazaki, Makoto Yoshimitsu, Junya Kuroda, Norifumi Tsukamoto, Hideki Tsujimura, Kensuke Usuki, Takahiro Yamauchi, Takahiko Utsumi, Ishikazu Mizuno, Yasushi Takamatsu, Yasuyuki Nagata, Shuichi Ota, Eiichi Ohtsuka, Ichiro Hanamura, Yasuhiro Suzuki, Shinichiro Yoshida, Satoshi Yamasaki, Youko Suehiro, Yutaro Kamiyama, Suguru Fukuhara, Kunihiro Tsukasaki, Hirokazu Nagai
CANCER SCIENCE (2022)
Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE-1 (phase 2) Japanese cohort
Masaki Ri, Kenshi Suzuki, Tadao Ishida, Junya Kuroda, Taku Tsukamoto, Takanori Teshima, Hideki Goto, Carolyn C. Jackson, Huabin Sun, Lida Pacaud, Ei Fujikawa, Tzu-Min Yeh, Tomoyoshi Hatayama, Kensuke Aida, Yoshihiro Sunagawa, Shinsuke Iida
CANCER SCIENCE (2022)
Neurolymphomatosis of cranial nerves as the responsible lesions for the vocal cord paralysis and facial nerve palsy in a patient with diffuse large B-cell lymphoma
Yu Inoue, Koichi Hirakawa, Hiroki Hayata, Daichi Nishiyama, Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Junya Kuroda
ANNALS OF HEMATOLOGY (2023)
Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia
Satoshi Wakita, Atsushi Marumo, Kaoru Morita, Shinichi Kako, Takashi Toya, Yuho Najima, Noriko Doki, Junya Kanda, Junya Kuroda, Shinichiro Mori, Atsushi Satake, Kensuke Usuki, Toshimitsu Ueki, Nobuhiko Uoshima, Yutaka Kobayashi, Eri Kawata, Kazutaka Nakayama, Yuhei Nagao, Katsuhiro Shono, Motoharu Shibusawa, Jiro Tadokoro, Masao Hagihara, Hitoji Uchiyama, Naoyuki Uchida, Yasushi Kubota, Shinya Kimura, Hisao Nagoshi, Tatsuo Ichinohe, Saiko Kurosawa, Sayuri Motomura, Akiko Hashimoto, Hideharu Muto, Eriko Sato, Masao Ogata, Kenjiro Mitsuhashi, Jun Ando, Haruko Tashiro, Masahiro Sakaguchi, Shunsuke Yui, Kunihito Arai, Tomoaki Kitano, Miho Miyata, Haruka Arai, Masayuki Kanda, Kako Itabashi, Takahiro Fukuda, Yoshinobu Kanda, Hiroki Yamaguchi
CANCER SCIENCE (2023)
Tumour-derived exosomes promote the induction of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells by delivering miR-106a-5p and miR-146a-5p in multiple myeloma
Kentaro Mizuhara, Yuji Shimura, Taku Tsukamoto, Akinori Kanai, Saeko Kuwahara-Ota, Junko Yamaguchi, Ayako Muramatsu, Haruya Okamoto, Yoko Taminishi-Katsuragawa, Yuka Kawaji-Kanayama, Reiko Isa, Shinsuke Mizutani, Toshiya Inaba, Junya Kuroda
BRITISH JOURNAL OF HAEMATOLOGY (2023)
Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum
Yuji Shimura, Hirohiko Shibayama, Aya Nakaya, Ryosuke Yamamura, Kazunori Imada, Hitomi Kaneko, Hitoshi Hanamoto, Shin-ichi Fuchida, Hirokazu Tanaka, Satoru Kosugi, Miki Kiyota, Toshimitsu Matsui, Junya Kanda, Masato Iida, Mitsuhiro Matsuda, Nobuhiko Uoshima, Masaru Shibano, Takahiro Karasuno, Tsuneyoshi Hamada, Kensuke Ohta, Tomoki Ito, Hideo Yagi, Satoshi Yoshihara, Chihiro Shimazaki, Shosaku Nomura, Masayuki Hino, Akifumi Takaori-Kondo, Itaru Matsumura, Yuzuru Kanakura, Junya Kuroda
INTERNATIONAL JOURNAL OF HEMATOLOGY (2023)
Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial
Tsutomu Kobayashi, Kazuhito Yamamoto, Yoshitoyo Kagami, Ryunosuke Machida, Kana Miyazaki, Shigeo Nakamura, Junya Kuroda, Dai Maruyama, Hirokazu Nagai
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2022)